Torasemide PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified PCD pharma franchise company offering Torasemide — currently 2 formulations in tablet form — to distributors and franchise partners across India, with district-level monopoly rights. Torasemide is the International Non-proprietary Name for the molecule also marketed as torsemide; if you are looking for the injection and the wider tablet set, see our Torsemide franchise range.
What is Torasemide?
Torasemide is a loop diuretic. It acts on the thick ascending limb of the loop of Henle, where it inhibits the sodium-potassium-two-chloride (Na-K-2Cl) cotransporter, preventing the reabsorption of sodium and chloride and drawing water out with them. The result is a strong, sustained diuresis that relieves fluid overload. Compared with furosemide, it is absorbed more completely and predictably from the gut and acts for longer. It is prescription-only and requires monitoring of electrolytes and renal function. Compound and pharmacology data are available on PubChem.
Torasemide Formulations Available with Cafoli Lifecare
This listing comprises 2 formulations in tablet form. Strength, packing and net rate details are shared with registered franchise enquiries.
Therapeutic Applications of Torasemide
- Oedema and fluid overload in congestive heart failure
- Oedema associated with chronic kidney disease
- Ascites and oedema in hepatic cirrhosis
- Hypertension, particularly where a diuretic is needed alongside other antihypertensives
Prescribers are cardiologists, nephrologists, hepatologists and general physicians. Electrolyte and renal monitoring is part of routine therapy.
Why Torasemide is a High-Potential Molecule for Distributors
Heart failure is one of the fastest-growing chronic disease burdens in India, and diuretics are the one class almost every symptomatic patient stays on. What makes Torasemide interesting rather than merely necessary is that it is actively taking share from furosemide: its near-complete oral absorption holds up even in patients whose gut is congested, which is exactly the population that fails on furosemide and ends up back in hospital. Cardiologists therefore switch patients across deliberately, and once switched they rarely switch back. For a distributor, that produces the best kind of demand — a chronic, daily, indefinite medicine with a prescriber-driven migration trend running in its favour, and a small, easily covered specialist base to detail to.
Why Choose Cafoli Lifecare for Your Torasemide Franchise
- Monopoly rights — one partner per district, territory protected
- WHO-GMP certified manufacturing and DCGI-approved formulations
- Promotional inputs — visual aids, doctor sample packs, literature, reminder gifts and MR bags
- 1000+ franchise partners across India
- On-time despatch, transparent net rates and dedicated order support
References
- PubChem — Torasemide compound record, National Library of Medicine
- PubMed — clinical literature on torasemide in heart failure
- WHO Model List of Essential Medicines
Our formulations of Torasemide find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: